References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
People living with HIV in the UK today can expect a near-normal lifespan when diagnosed early and treated effectively. A 20-year-old starting modern antiretroviral therapy (ART) has a life expectancy close to that of the general population. This is one of the most dramatic changes in medicine over the past 30 years — HIV has moved from a fatal diagnosis to a manageable long-term condition.
Here’s what the evidence shows.
Order a discreet home HIV test
What the Studies Show
Large studies from the UK, Europe and North America have consistently shown that life expectancy for people with HIV on effective treatment is approaching normal. Key findings:
- People diagnosed and treated promptly have close to normal life expectancy
- Late diagnosis (low CD4 count at start) reduces life expectancy, but outcomes are still much better than without treatment
- Smoking and other lifestyle factors now affect HIV-positive people’s life expectancy more than HIV itself
- Older drugs had more side effects and complications; modern drugs are much better tolerated
Factors That Affect Life Expectancy
| Factor | Impact |
|---|---|
| Early diagnosis | Major positive |
| Consistent ART adherence | Critical for long-term outcomes |
| Undetectable viral load | Near-normal life expectancy |
| Late diagnosis (CD4 below 200) | Reduced but still significantly improved |
| Smoking | Now a bigger threat than HIV itself for many |
| Cardiovascular health | Important — HIV raises cardiovascular risk |
| Mental health | Strongly affects long-term outcomes |
The Timeline of HIV
It’s useful to understand how treatment has changed the timeline:
- Pre-1996: No effective treatment; median survival 10-11 years
- 1996-2000s: First combination therapy; substantial improvement but significant side effects
- 2010s: Modern drugs with fewer side effects; near-normal life expectancy for those diagnosed early
- Now: Single-tablet regimens, long-acting injectables, and active cure research
Living Well With HIV
For most people today, the factors that affect long-term health are similar to those affecting the general population:
- Stop smoking
- Eat a balanced diet
- Stay active
- Manage blood pressure, cholesterol and blood sugar
- Look after mental health
- Attend regular clinic appointments
- Stay on treatment
Late Diagnosis Is the Biggest Risk
The single biggest factor affecting HIV-related deaths in the UK today is late diagnosis — people who don’t know they have HIV until their immune system has already been significantly damaged. Regular testing catches HIV early, when treatment has the most benefit.
Read more: Life expectancy with HIV | Untreated HIV | HIV and the immune system
Frequently Asked Questions
How long can I live with HIV?
With early diagnosis and effective treatment, near normal life expectancy. A 20-year-old starting ART today has an expected lifespan close to that of the general population.
Does HIV still shorten life?
Modestly for people diagnosed early and on effective treatment. Late diagnosis still significantly affects life expectancy.
What’s the biggest threat to my health if I have HIV?
In the modern era, smoking, cardiovascular disease and other lifestyle factors are often bigger threats than HIV itself for people on effective ART.
Related reading
- Blood Test for Syphilis, Hepatitis B and Hepatitis C
- Can You Get an STI From Being Fingered?
- Can You Catch an STI From a Toilet Seat?
- Can You Clear HPV Once You Have It?
- Can You Die From Hepatitis B?
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data

Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.



